• Mashup Score: 0
    Cannabis Inhalation Acutely Reduces Muscle Sympathetic Nerve Activity in Humans - 1 year(s) ago

    Jamie F. Burr Correspondence to: Jamie F. Burr, University of Guelph, 50 Stone Road East, Ontario, Canada N1G 2W1, Email E-mail Address: [email protected]; or Philip J. Millar, University of Guelph, 50 Stone Road East, Guelph, Ontario, Canada N1G 2W1, Email E-mail Address: [email protected] https://orcid.org/0000-0002-5449-3352 Human Health and Nutritional Sciences, University of Guelph,…

    Source: Circulation
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CircAHA
      CircAHA

      #OriginalResearch simpub #AHA2022: Cannabis Inhalation Acutely Reduces Muscle Sympathetic Nerve Activity in Humans @cp_cheung @massnardone @JorB_L @Millar_Lab @Dr_Burr @uofg #AHAJournals https://t.co/6ut62YqbFi

  • Mashup Score: 0
    PHOTO GALLERY: AHA 2022 - 1 year(s) ago

    Around the web Amgen’s newly created subsidiary, Pillartree Limited, will acquire Horizon Therapeutics for $116.50 per share in cash. That’s a premium of 19.7% above the closing price of $97.29 on Dec. 9, 2022. Physicians are now bracing for payment cuts after the Centers for…

    Source: Cardiovascular Business
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ToddVillinesMD
      ToddVillinesMD

      Big thanks 🙏🙏 to @DaveFornell & team at Cardiovascular Business for highlighting the @ElucidBio comprehensive plaque and novel FFRct software as presented and demonstrated at #AHA2022 !! 👉 https://t.co/d21aKacQ7d #yesCCT

  • Mashup Score: 0
    Is Finding and Fixing Iron Deficiency in HF Beneficial? - 1 year(s) ago

    Ileana Piña interviews Paul Kalra about the IRONMAN trial from the American Heart Association which randomized HF patients with iron deficiency to IV ferric derisomaltose repletion or no infusions.

    Source: Medscape
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of theheartorg
      theheartorg

      Ileana Piña interviews Paul Kalra about the IRONMAN trial from the @American_Heart which randomized HF patients with iron deficiency to IV ferric derisomaltose repletion or no infusions. https://t.co/fLoGBdc2IW #AHA22 #Cardiology #CardioTwitter #AHA2022 https://t.co/yjG4AsTpD0

  • Mashup Score: 0
    Links to the American Heart Association 2022 late-breaking studies - 1 year(s) ago

    Emerging Heart Failure Science FS.04, Monday, Nov. 7, 8-9 a.m.    • Safety and Efficacy of Non-Ischemic Hypothermic Machine Perfusion (NIHP) in Human Heart Transplantation With an Ischemic Time of 6-8 Hours    • A Randomized, Multicenter, Placebo-Controlled Trial of the Beta3 Adrenergic Agonist, Mirabegron on Left Ventricular Mass and Diastolic Function in Patients With Structural Heart…

    Source: Cardiovascular Business
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardioBusiness
      CardioBusiness

      Links to the American Heart Association 2022 late-breaking studies #Cardiotwitter #AHA #AHA22 #AHA2022 https://t.co/p763ELqnh1

  • Mashup Score: 4
    Top 10 Highlights of AHA 2022 - Cardiology Update - 1 year(s) ago

    The American Heart Association (AHA) 2022 scientific sessions took place at the McCormick Place Convention Center in Chicago, USA from November 5 – 7, 2022. Here are our top 10 highlights of AHA 2022.

    Source: Cardiology Update
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardiolUpdate
      CardiolUpdate

      #AHA2022 Highlights https://t.co/R1Lc2rR2RV @chadialraies @mirvatalasnag @mmamas1973 @manesh_patelMD @ekgpdx @djc795 @Almanfi_Cardio @DrAmirKaki @lamelaspablo @RajTayal2 @DocSavageTJU @ZaherFanari @rajivxgulati @KaulP @torresviera @ALEX_MISCHIE @RodrigoBagur @SuzanneJBaron https://t.co/4VYZjBqVOC

  • Mashup Score: 0
    American Heart Association Honors Distinguished Scientists at AHA22 - 1 year(s) ago

    November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022). The AHA designates the Distinguished Scientist award for members who have “significantly advanced the understanding of cardiovascular, stroke or brain health.” A summary of the profiles offered by the AHA of its honorees follows. Emelia J. Benjamin, MD, ScM, FAHA Professor of…

    Source: DAIC
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @AHAMeetings Seven awardees were honored during #AHA2022. The AHA designates the #DistinguishedScientist award for members who have “significantly advanced the understanding of #cardiovascular, #stroke or #brain health.” https://t.co/LRwbzS2CVH

  • Mashup Score: 0
    Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022 - 1 year(s) ago

    November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be used regularly in hospitals and practices around the world — changing future treatment, said Ann Marie Schmidt, MD, FAHA. The insights were made during the American Heart Association Annual Scientific Session 2022, held Nov. 5-7 in Chicago, IL. “The concept of therapeutic,…

    Source: DAIC
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @AHAMeetings New #genomic therapies for #cardiovasculardisease are reaching the #clinicaltrial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (#AHA2022): https://t.co/6gSDXfBvOF

Load More